Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine

References

• Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005;1:252-62
   PubMed Web of Science ®Google Scholar
• Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 2009;11:49-79
   PubMed Web of Science ®Google Scholar
• Katoh M. Great challenges in molecular medicine: toward personalized medicine. Front Cell Dev Biol 2013;1:1
   PubMed Web of Science ®Google Scholar
• Witze ES, Old WM, Resing KA, et al. Mapping protein post-translational modifications with mass spectrometry. Nat Methods 2007;4:798-806
   PubMed Web of Science ®Google Scholar
• Ewing RM, Chu P, Elisma F, et al. Large-scale mapping of human protein–protein interactions by mass spectrometry. Mol Syst Biol 2007;3:89
   PubMed Web of Science ®Google Scholar
• Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012;13:227-32
   PubMed Web of Science ®Google Scholar
• Giri NC, Passantino L, Sun H, et al. Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy. Biochemistry 2013;52:4168-83
   PubMed Web of Science ®Google Scholar
• Agyeman A, Jha BK, Mazumdar T, et al. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding. Oncotarget 2014;5:4492-503
   PubMed Web of Science ®Google Scholar
• Chu CH, Wang LY, Hsu KC, et al. KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. J Med Chem 2014;57:5975-85
   PubMed Web of Science ®Google Scholar
• Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011;10:47-60
   PubMed Web of Science ®Google Scholar
• Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 2009;9:873-86
   PubMed Web of Science ®Google Scholar
• Irvine DA, Copland M. Targeting hedgehog in hematologic malignancy. Blood 2012;119:2196-204
   PubMed Web of Science ®Google Scholar
• Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics. Med Res Rev 2014;34:280-300
   PubMed Web of Science ®Google Scholar
• Klein T, Tucker J, Holdgate GA, et al. FGFR1 kinase inhibitors: close gegioisomers adopt divergent binding modes and display distinct biophysical signatures. ACS Med Chem Lett 2013;5:166-71
   PubMed Web of Science ®Google Scholar
• Tan L, Wang J, Tanizaki J, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proc Natl Acad Sci USA 2014;111:E4869-77
   PubMed Web of Science ®Google Scholar
• Holliday R. The inheritance of epigenetic defects. Science 1987;238:163-70
   PubMed Web of Science ®Google Scholar
• Berger SL, Kouzarides T, Shiekhattar R, et al. An operational definition of epigenetics. Genes Dev 2009;23:781-3
   PubMed Web of Science ®Google Scholar
• Katoh M. Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases. Front Cell Dev Biol 2014;2:61
   PubMed Web of Science ®Google Scholar
• Baylin SB, Jones PA. A decade of exploring the cancer epigenome: biological and translational implications. Nat Rev Cancer 2011;11:726-34
   PubMed Web of Science ®Google Scholar
• Simó-Riudalbas L, Esteller M. Cancer genomics identifies disrupted epigenetic genes. Hum Genet 2014;133:713-25
   PubMed Web of Science ®Google Scholar
• Ordovás JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010;7:510-19
   PubMed Web of Science ®Google Scholar
• Bravo GM, Lee E, Merchan B, et al. Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution. Br J Haematol 2014;166:646-59
   PubMed Web of Science ®Google Scholar
• Di Costanzo A, Del Gaudio N, Migliaccio A, et al. Epigenetic drugs against cancer: an evolving landscape. Arch Toxicol 2014;88:1651-68
   Google Scholar
• Rose NR, Woon EC, Kingham GL, et al. Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. J Med Chem 2010;53:1810-18
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012;150:12-27
   PubMed Web of Science ®Google Scholar
• Kwa FA, Thrimawithana TR. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy. Drug Discov Today 2014;19:1387-93
   PubMed Web of Science ®Google Scholar
• Machida YJ, Machida Y, Vashisht AA, et al. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 2009;284:34179-88
   PubMed Web of Science ®Google Scholar
• Dey A, Seshasayee D, Noubade R, et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 2012;337:1541-6
   PubMed Web of Science ®Google Scholar
• Mayya V, Lundgren DH, Hwang SI, et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein–protein interactions. Sci Signal 2009;2:ra46
   PubMed Web of Science ®Google Scholar
• Dephoure N, Zhou C, Villén J, et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008;105:10762-7
   PubMed Web of Science ®Google Scholar
• Bönisch C, Nieratschker SM, Orfanos NK, et al. Chromatin proteomics and epigenetic regulatory circuits. Expert Rev Proteomics 2008;5:105-19
   PubMed Web of Science ®Google Scholar
• Fisher CL, Berger J, Randazzo F, et al. A human homolog of Additional sex combs, ADDITIONAL SEX COMBS-LIKE 1, maps to chromosome 20q11. Gene 2003;306:115-26
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Identification and characterization of ASXL2 gene in silico. Int J Oncol 2003;23:845-50
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Identification and characterization of ASXL3 gene in silico. Int J Oncol 2004;24:1617-22
   PubMed Web of Science ®Google Scholar
• Sinclair DA, Milne TA, Hodgson JW, et al. The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes. Development 1998;125:1207-16
   PubMedGoogle Scholar
• Gelsi-Boyer V, Trouplin V, Adélaïde J, et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 2009;145:788-800
   PubMed Web of Science ®Google Scholar
• Hoischen A, van Bon BW, Rodríguez-Santiago B, et al. De novo nonsense mutations in ASXL1 cause Bohring–Opitz syndrome. Nat Genet 2011;43:729-31
   PubMed Web of Science ®Google Scholar
• Bainbridge MN, Hu H, Muzny DM, et al. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring–Opitz syndrome. Genome Med 2013;5:11
   PubMed Web of Science ®Google Scholar
• Katoh M. Functional and cancer genomics of ASXL family members. Br J Cancer 2013;109:299-306
   PubMed Web of Science ®Google Scholar
• Scheuermann JC, de Ayala Alonso AG, Oktaba K, et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010;465:243-7
   PubMed Web of Science ®Google Scholar
• White AE, Harper JW. Emerging anatomy of the BAP1 tumor suppressor system. Science 2012;337:1463-4
   PubMed Web of Science ®Google Scholar
• Cho YS, Kim EJ, Park UH, et al. Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor. J Biol Chem 2006;28:17588-98
   Google Scholar
• Abdel-Wahab O, Adli M, LaFave LM, et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 2012;22:180-93
   PubMed Web of Science ®Google Scholar
• Lai HL, Wang QT. Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets. PLoS One 2013;8:e73983
   Web of Science ®Google Scholar
• Khan FF, Li Y, Balyan A, et al. WTIP interacts with ASXL2 and blocks ASXL2-mediated activation of retinoic acid signaling. Biochem Biophys Res Commun 2014;451:101-6
   PubMed Web of Science ®Google Scholar
• Avila M, Kirchhoff M, Marle N, et al. Delineation of a new chromosome 20q11.2 duplication syndrome including the ASXL1 gene. Am J Med Genet A 2013;161:1594-8
   Google Scholar
• Scotto L, Narayan G, Nandula SV, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 2008;47:755-65
   PubMed Web of Science ®Google Scholar
• De Rubeis S, He X, Goldberg AP, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014;515:209-15
   PubMed Web of Science ®Google Scholar
• Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B 2011;156:255-74
   Web of Science ®Google Scholar
• Russell B, Graham JMJr. Expanding our knowledge of conditions associated with the ASXL gene family. Genome Med 2013;5:16
   PubMed Web of Science ®Google Scholar
• Gelsi-Boyer V, Brecqueville M, Devillier R, et al. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol 2012;5:12
   PubMed Web of Science ®Google Scholar
• Micol JB, Duployez N, Boissel N, et al. Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations. Blood 2014;124:1445-9
   PubMed Web of Science ®Google Scholar
• Metzeler KH. ASXL genes and RUNX1: an intimate connection? Blood 2014;124:1382-3
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Tarpey PS, Davies H, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012;486:400-4
   PubMed Web of Science ®Google Scholar
• Grasso CS, Wu YM, Robinson DR, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012;487:239-43
   PubMed Web of Science ®Google Scholar
• Williams DS, Bird MJ, Jorissen RN, et al. Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability. PLoS One 2010;5:e16012
   Web of Science ®Google Scholar
• Huether R, Dong L, Chen X, et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun 2014;5:3630
   PubMed Web of Science ®Google Scholar
• Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333:1157-60
   PubMed Web of Science ®Google Scholar
• Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011;43:828-9
   PubMed Web of Science ®Google Scholar
• Balbás-Martínez C, Sagrera A. Carrillo-de-Santa-Pau E, et al. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet 2013;45:1464-9
   PubMed Web of Science ®Google Scholar
• Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6
   PubMed Web of Science ®Google Scholar
• Berger MF, Hodis E, Heffernan TP, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012;485:502-6
   PubMed Web of Science ®Google Scholar
• Kanchi KL, Johnson KJ, Lu C, et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun 2014;5:3156
   PubMed Web of Science ®Google Scholar
• Inoue D, Kitaura J, Togami K, et al. Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations. J Clin Invest 2013;123:4627-40
   PubMed Web of Science ®Google Scholar
• Park UH, Yoon SK, Park T, et al. Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor γ. J Biol Chem 2011;286:1354-63
   PubMed Web of Science ®Google Scholar
• Park UH, Seong MR, Kim EJ, et al. Reciprocal regulation of LXRα activity by ASXL1 and ASXL2 in lipogenesis. Biochem Biophys Res Commun 2014;443:489-94
   PubMed Web of Science ®Google Scholar
• Evans RM. The nuclear receptor superfamily: a rosetta stone for physiology. Mol Endocrinol 2005;19:1429-38
   PubMed Web of Science ®Google Scholar
• Gadaleta RM, Magnani L. Nuclear receptors and chromatin: an inducible couple. J Mol Endocrinol 2014;52:R137-49
   Web of Science ®Google Scholar
• Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010;24:1967-2000
   PubMed Web of Science ®Google Scholar
• Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82
   PubMed Web of Science ®Google Scholar
• Moore JT, Collins JL, Pearce KH. The nuclear receptor superfamily and drug discovery. ChemMedChem 2006;1:504-23
   PubMed Web of Science ®Google Scholar
• Hervouet E, Cartron PF, Jouvenot M, et al. Epigenetic regulation of estrogen signaling in breast cancer. Epigenetics 2013;8:237-45
   PubMed Web of Science ®Google Scholar
• Aasland R, Gibson TJ, Stewart AF. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995;20:56-9
   PubMed Web of Science ®Google Scholar
• Schuettengruber B, Chourrout D, Vervoort M, et al. Genome regulation by polycomb and trithorax proteins. Cell 2007;128:735-45
   PubMed Web of Science ®Google Scholar
• Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 2007;8:9-22
   PubMed Web of Science ®Google Scholar
• Li H, Ilin S, Wang W, et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006;442:91-5
   PubMed Web of Science ®Google Scholar
• Shi XB, Hong T, Walter KL, et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006;442:96-9
   PubMed Web of Science ®Google Scholar
• Baker LA, Allis CD, Wang GG. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mut Res 2008;647:3-12
   PubMed Web of Science ®Google Scholar
• Chi P, Allis CD, Wang GG. Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010;10:457-69
   PubMed Web of Science ®Google Scholar
• Sanchez R, Zhou MM. The PHD finger: a versatile epigenome reader. Trends Biochem Sci 2011;36:364-72
   PubMed Web of Science ®Google Scholar
• Li Y, Li H. Many keys to push: diversifying the ‘readership’ of plant homeodomain fingers. Acta Biochim Biophys Sin 2012;44:28-39
   Google Scholar
• Liu L, Qin S, Zhang J, et al. Solution structure of an atypical PHD finger in BRPF2 and its interaction with DNA. J Struct Biol 2012;180:165-73
   Google Scholar
• Liu Z, Li F, Ruan K, et al. Structural and functional insights into the human Börjeson–Forssman–Lehmann syndrome-associated protein PHF6. J Biol Chem 2014;289:10069-83
   PubMed Web of Science ®Google Scholar
• Gatchalian J, Fütterer A, Rothbart SB, et al. Dido3 PHD modulates cell differentiation and division. Cell Rep 2013;4:148-58
   PubMed Web of Science ®Google Scholar
• Ooi SK, Qiu C, Bernstein E, et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007;448:714-17
   PubMed Web of Science ®Google Scholar
• Soliman MA, Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci 2007;32:509-19
   PubMedGoogle Scholar
• Boulay G, Rosnoblet C, Guerardel C, et al. Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes. Biochem J 2011;434:333-42
   PubMedGoogle Scholar
• Wang GG, Song J, Wang Z, et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009;459:847-51
   PubMed Web of Science ®Google Scholar
• Vermeulen M, Mulder KW, Denissov S, et al. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007;131:58-69
   PubMed Web of Science ®Google Scholar
• Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004;61:2571-87
   PubMed Web of Science ®Google Scholar
• Yang XJ, Ullah M. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene 2007;26:5408-19
   PubMed Web of Science ®Google Scholar
• Ali M, Hom RA, Blakeslee W, et al. Diverse functions of PHD fingers of the MLL/KMT2 subfamily. Biochim Biophys Acta 2014;1843:366-71
   PubMed Web of Science ®Google Scholar
• Lemak A, Yee A, Wu H, et al. Solution NMR structure and histone binding of the PHD domain of human MLL5. PLoS One 2013;8:e77020
   Web of Science ®Google Scholar
• Angrand P, Apiou F, Stewart AF, et al. NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 2001;74:79-88
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Identification and characterization of JMJD2 family genes in silico. Int J Oncol 2004;24:1623-8
   PubMed Web of Science ®Google Scholar
• Berry WL, Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res 2013;73:2936-42
   PubMed Web of Science ®Google Scholar
• Labbé RM, Holowatyj A, Yang ZQ. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am J Transl Res 2014;6:1-15
   Web of Science ®Google Scholar
• Leurs U, Lohse B, Rand KD, et al. Substrate- and cofactor-independent inhibition of histone demethylase KDM4C. ACS Chem Biol 2014;9:2131-8
   PubMed Web of Science ®Google Scholar
• Klose RJ, Kallin EM, Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 2006;7:715-27
   PubMed Web of Science ®Google Scholar
• Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007;25:1-14
   PubMed Web of Science ®Google Scholar
• Klein BJ, Piao L, Xi Y, et al. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep 2014;6:325-35
   PubMed Web of Science ®Google Scholar
• Johansson C, Tumber A, Che K, et al. The roles of Jumonji-type oxygenases in human disease. Epigenomics 2014;6:89-120
   PubMed Web of Science ®Google Scholar
• Wen H, Li J, Song T, et al. Recognition of histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates histone demethylation. J Biol Chem 2010;285:9322-6
   PubMed Web of Science ®Google Scholar
• Feng W, Yonezawa M, Ye J, et al. PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation. Nat Struct Mol Biol 2010;17:445-50
   PubMed Web of Science ®Google Scholar
• Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007;25:15-30
   PubMed Web of Science ®Google Scholar
• Aravind L, Iyer LM. The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modifications. Cell Cycle 2012;11:119-31
   PubMed Web of Science ®Google Scholar
• Trelle MB, Jensen ON. Functional proteomics in histone research and epigenetics. Expert Rev Proteomics 2007;4:491-503
   PubMed Web of Science ®Google Scholar
• Han Y, Garcia BA. Combining genomic and proteomic approaches for epigenetics research. Epigenomics 2013;5:1-14
   PubMed Web of Science ®Google Scholar
• Shih AH, Abdel-Wahab O, Patel JP, et al. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer 2012;12:599-612
   PubMed Web of Science ®Google Scholar
• Cazzola M, Della Porta MG, Malcovati L. The genetic basis of myelodysplasia and its clinical relevance. Blood 2013;122:4021-34
   PubMed Web of Science ®Google Scholar
• Mehdipour P, Santoro F, Minucci S. Epigenetic alterations in acute myeloid leukemias. FEBS J 2015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014;28:241-7
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Abdel-Wahab O, Lu C, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010;18:553-67
   PubMed Web of Science ®Google Scholar
• Deb G, Thakur VS, Gupta S. Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond. Epigenetics 2013;8:464-76
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tong T. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis. Biochem Biophys Res Commun 2014;453(1):172-8
   PubMed Web of Science ®Google Scholar
• Tan J, Yan Y, Wang X, et al. EZH2: biology, disease, and structure-based drug discovery. Acta Pharmacol Sinica 2014;35:161-74
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature 2010;468:1067-73
   PubMed Web of Science ®Google Scholar
• Simhadri C, Daze KD, Douglas SF, et al. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). J Med Chem 2014;57:2874-83
   PubMed Web of Science ®Google Scholar
• Wagner EK, Nath N, Flemming R, et al. Identification and characterization of small molecule inhibitors of a plant homeodomain finger. Biochemistry 2012;51:8293-306
   PubMed Web of Science ®Google Scholar
• Gough SM, Lee F, Yang F, et al. NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function. Cancer Discov 2014;4:564-77
   PubMed Web of Science ®Google Scholar
• Metzeler KH, Becker H, Maharry K, et al. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN favorable genetic category. Blood 2011;118:6920-9
   PubMed Web of Science ®Google Scholar
• Baskind HA, Na L, Ma Q, et al. Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx. PLoS One 2009;4:e4750
   Web of Science ®Google Scholar
• McGinley AL, Li Y, Deliu Z, et al. Additional sex combs-like family genes are required for normal cardiovascular development. Genesis 2014;52:671-86
   PubMed Web of Science ®Google Scholar
• Brezinova J, Sarova I, Buryova H, et al. Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome. Br J Haematol 2014;164:153-5
   PubMed Web of Science ®Google Scholar
• Nakahata S, Saito Y, Hamasaki M, et al. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma. Genes Chromosomes Cancer 2009;48:768-76
   PubMed Web of Science ®Google Scholar
• Chinen Y, Taki T, Tsutsumi Y, et al. The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t (8;19) (p11;q13). Genes Chromosomes Cancer 2014;53:299-308
   PubMed Web of Science ®Google Scholar